Unknown

Dataset Information

0

4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.


ABSTRACT: Osteogenesis imperfecta (OI) is a heritable brittle bone disease mainly caused by mutations in the two type I collagen genes. Collagen synthesis is a complex process including trimer formation, glycosylation, secretion, extracellular matrix (ECM) formation, and mineralization. Using OI patient-derived fibroblasts and induced pluripotent stem cells (iPSCs), we investigated the effect of 4-phenylbutyric acid (4-PBA) on collagen synthesis to test its potential as a new treatment for OI. Endoplasmic reticulum (ER) retention of type I collagen was observed by immunofluorescence staining in OI patient-derived fibroblasts with glycine substitution and exon skipping mutations. Liquid chromatography-mass spectrometry analysis revealed excessive glycosylation of secreted type I collagen at the specific sites in OI cells. The misfolding of the type I collagen triple helix in the ECM was demonstrated by the incorporation of heat-dissociated collagen hybridizing peptide in OI cells. Type I collagen was produced excessively by OI fibroblasts with a glycine mutation, but this excessive production was normalized when OI fibroblasts were cultured on control fibroblast-derived ECM. We also found that mineralization was impaired in osteoblasts differentiated from OI iPSCs. In summary, treatment with 4-PBA normalizes the excessive production of type I collagen, reduces ER retention, partially improves misfolding of the type I collagen helix in ECM, and improves osteoblast mineralization. Thus, 4-PBA may improve not only ER retention, but also type I collagen synthesis and mineralization in human cells from OI patients.

SUBMITTER: Takeyari S 

PROVIDER: S-EPMC7948972 | biostudies-literature | 2021 Jan-Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

4-Phenylbutyric acid enhances the mineralization of osteogenesis imperfecta iPSC-derived osteoblasts.

Takeyari Shinji S   Kubota Takuo T   Ohata Yasuhisa Y   Fujiwara Makoto M   Kitaoka Taichi T   Taga Yuki Y   Mizuno Kazunori K   Ozono Keiichi K  

The Journal of biological chemistry 20201123


Osteogenesis imperfecta (OI) is a heritable brittle bone disease mainly caused by mutations in the two type I collagen genes. Collagen synthesis is a complex process including trimer formation, glycosylation, secretion, extracellular matrix (ECM) formation, and mineralization. Using OI patient-derived fibroblasts and induced pluripotent stem cells (iPSCs), we investigated the effect of 4-phenylbutyric acid (4-PBA) on collagen synthesis to test its potential as a new treatment for OI. Endoplasmic  ...[more]

Similar Datasets

| S-EPMC1133019 | biostudies-other
| S-EPMC9652255 | biostudies-literature
| S-EPMC5010570 | biostudies-literature
| PRJEB12324 | ENA
| PRJEB66425 | ENA
| S-EPMC7384887 | biostudies-literature
| S-EPMC8855815 | biostudies-literature
| S-EPMC4649292 | biostudies-literature
| S-EPMC8359849 | biostudies-literature
| S-EPMC1181952 | biostudies-literature